Reversal of Opioid‐Induced Respiratory Depression in Healthy Volunteers: Comparison of Intranasal Nalmefene and Intranasal Naloxone.

MLA

Ellison, Mark, et al. “Reversal of Opioid‐Induced Respiratory Depression in Healthy Volunteers: Comparison of Intranasal Nalmefene and Intranasal Naloxone.” Journal of Clinical Pharmacology, vol. 64, no. 7, July 2024, pp. 828–39. EBSCOhost, https://doi.org/10.1002/jcph.2421.

APA

Ellison, M., Hutton, E., Webster, L., & Skolnick, P. (2024). Reversal of Opioid‐Induced Respiratory Depression in Healthy Volunteers: Comparison of Intranasal Nalmefene and Intranasal Naloxone. Journal of Clinical Pharmacology, 64(7), 828–839. https://doi.org/10.1002/jcph.2421

Chicago

Ellison, Mark, Emily Hutton, Lynn Webster, and Phil Skolnick. 2024. “Reversal of Opioid‐Induced Respiratory Depression in Healthy Volunteers: Comparison of Intranasal Nalmefene and Intranasal Naloxone.” Journal of Clinical Pharmacology 64 (7): 828–39. doi:10.1002/jcph.2421.